Enerisant

DB20605ExperimentalSmall molecule

Enerisant is a small molecule drug. The usage of the INN stem '-isant' in the name indicates that Enerisant is a histamine H3 receptor antagonist. Enerisant has a monoisotopic molecular...

Mechanism: Pharmacologically active on Histamine H3 receptor
Curator reviewed
Formula / weight: C₂₂H₃₀N₄O₃ · 398.507 g/mol (avg)

Resolves to

Compound

UNIIE2Y97PQY3ACAS1152747-82-4

Structure

InChIKeyIABXVJILZYNSTM-GOSISDBHSA-NSMILESC[C@@H]1CCCN1CCCOC1=CC=C(C=C1)N1C=C(C=N1)C(=O)N1CCOCC1

Targets

Q9Y5N1HRH3

Transporters

P08183ABCB1O15244SLC22A2Q96FL8SLC47A1Q86VL8SLC47A2

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4TransportersSubstrate / inhibitor direction, not just membership

Listed above

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Enerisant, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account